At a glance
ClinicalIndex Comparison RecordN/ACompleted· 550 enrolled
Drug / intervention
SL-ECGother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
AF Stroke Substudy SL-ECG Versus 12lead ECG
In Brief
An observational study evaluating SL-ECG for ECG and 2 related conditions. Completed, enrolled 550 participants across 1 site.
Detailed Summary
The purpose of the study is to compare parameters obtained per SL-ECG with the values from 12lead-ECG measurement. Patients who undergo out- or inpatient treatment and who receive a 12lead-ECG are asked to participate in this examination. Furthermore, 50 patients without heart disease should be included (control group).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsECG, Atrial Fibrillation, ECG Hand-held Diagnostic Tool
CountriesGermany
CollaboratorsPfizer
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
First PostedOct 2018
Primary CompletionMar 2019
TodayJul 2026
First PostedOct 23, 2018
Enrollment StartOct 9, 2018
Primary CompletionMar 26, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.7 years ago
Interventions
SL-ECGother
additional SL-ECG measurement